Cancer rates vary widely by state, race, CDC reports

February 21, 2013
Cancer rates vary widely by state, race: CDC report
Latest data from 2009 cites 1.5 million new cases diagnosed; prostate and breast tumors most common.

(HealthDay)—The latest U.S. cancer statistics find that 1.5 million new cases of invasive cancer were diagnosed among Americans in 2009, with more men than women developing malignancies and blacks at higher risk for cancer than whites.

The U.S. report reveals a nationwide annual rate of diagnoses of 459 cases per 100,000 adults, but incidence per state ranged widely, with higher rates for colon and lung cancers concentrated in the South.

Prostate, breast, lung and accounted for more than half of the cancers (52 percent) diagnosed in 2009, the CDC said. The report noted that the differing rates of prostate and breast cancers largely account for the observed racial and gender variations.

New cancer diagnoses increased with age, with more than 2,200 cases reported per 100,000 people aged 75 and older. The rate for people 50 to 64 was less than half that—843 per 100,000 individuals.

The 2009 data, derived from national cancer registries, does not include basal or squamous cell skin cancers or information from Wisconsin.

Many cancers are preventable, and breaking down their occurrence helps to monitor trends over time and improve preventive efforts.

"Populations defined by state of residence, race or ethnicity with high rates of cancer might benefit most from targeted cancer prevention and control efforts," the researchers said in the paper, which was published in the CDC's .

The overall cancer rate among men was 524 new cases per 100,000 people, with prostate cancer being most common, followed by lung and colon cancers. In Hispanic men, however, that order was reversed, the CDC said.

U.S. women had 414 new cases of cancer per 100,000 people in 2009. Breast cancer led the diagnoses, followed by lung, colon and uterine cancers. Hispanic women, however, had more cases of colon cancer than lung cancer.

There was one spot of bright news: The federal government's Healthy People 2020 goals have called for a reduction of colorectal cancers to 38.6 cases per 100,000, and the new report shows that the goal has already been met among women nationwide and among both genders in some states.

Cancers overall were more common in the Northeast and less common in Florida, the Southwest and California. But certain cancers were more prevalent in one region than others. For instance, lung cancer prevalence was greatest in Southern states, and colon cancer seemed concentrated in the South and Midwest. diagnoses were most common in the Pacific Northwest, the upper Midwest and parts of the Northeast, the report found.

Explore further: Cancer in African Americans: Gap closing for some sites, widening for others

More information: HealthyPeople.gov talks about U.S. national health goals.

Related Stories

Cancer in African Americans: Gap closing for some sites, widening for others

February 5, 2013
The cancer death rate for men declined faster among African Americans than among whites in the latest time period, narrowing the racial disparity in overall cancer death rates, according to a new report from the American ...

Cancer mortality down 20 percent from 1991 peak

January 17, 2013
Jan. 17, 2013–As of 2009, the overall death rate for cancer in the United States had declined 20 percent from its peak in 1991, translating to the avoidance of approximately 1.2 million deaths from cancer, 152,900 of these ...

CDC: breast cancer mortality higher in black women

November 15, 2012
(HealthDay)—With earlier detection and better treatment, the mortality rate from breast cancer has fallen over the last two decades; black women, however, still die from the disease at a disproportionately higher rate than ...

US lung cancer rates fall, led by Western states (Update)

September 15, 2011
The West is leading a national decline in the rate of new lung cancer cases, with states like California and Nevada accounting for much of the improvement, particularly among women.

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.